Literature DB >> 24120679

Preclinical immunogenicity and functional activity studies of an A+W meningococcal outer membrane vesicle (OMV) vaccine and comparisons with existing meningococcal conjugate- and polysaccharide vaccines.

G Tunheim1, M Arnemo, L M Næss, Å K Fjeldheim, L Nome, K Bolstad, A Aase, A Mandiarote, H González, D González, L García, D Cardoso, G Norheim, E Rosenqvist.   

Abstract

Meningococci of serogroups A and W (MenA and MenW) are the main causes of epidemic bacterial meningitis outbreaks in sub-Saharan Africa. In this study we prepared a detergent extracted outer membrane vesicle (dOMV) vaccine from representative African MenA and MenW strains, and compared the immunogenicity of this vaccine with existing meningococcal conjugate and polysaccharide (PS) vaccines in mice. NMRI mice were immunized with preclinical batches of the A+W dOMV vaccine, or with commercially available vaccines; a MenA conjugate vaccine (MenAfriVac(®), Serum Institute of India), ACYW conjugate vaccine (Menveo(®), Novartis) or ACYW PS vaccine (Mencevax(®), GlaxoSmithKline). The mice received 2 doses of 1/10 or 1/50 of a human dose with a three week interval. Immune responses were tested in ELISA, serum bactericidal activity (SBA) and opsonophagocytic activity (OPA) assays. High levels of IgG antibodies against both A and W dOMV were detected in mice receiving the A+W dOMV vaccine. High SBA titers against both MenA and MenW vaccine strains were detected after only one dose of the A+W dOMV vaccine, and the titers were further increased after the second dose. The SBA and OPA titers in mice immunized with dOMV vaccine were significantly higher than in mice immunized with the ACYW-conjugate vaccine or the PS vaccine. Furthermore, the A+W dOMV vaccine was shown to induce SBA and OPA titers against MenA of the same magnitude as the titers induced by the A-conjugate vaccine. In conclusion, the A+W dOMV vaccine induced high levels of functional antibodies to both MenA and MenW strains, levels that were shown to be higher or equal to the levels induced by licensed meningococcal vaccines. Thus, an A+W dOMV vaccine could potentially serve as an alternative or a supplement to existing conjugate and PS vaccines in the African meningitis belt.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Africa; Meningitis belt; Meningococcal disease; Neisseria meningitidis; OMV; OPA; Opsonophagocytic activity; Outer membrane protein; Outer membrane vesicle; SBA; Serum bactericidal activity; Vaccine

Mesh:

Substances:

Year:  2013        PMID: 24120679     DOI: 10.1016/j.vaccine.2013.09.044

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  3 in total

Review 1.  Bacterial outer membrane vesicles and vaccine applications.

Authors:  Reinaldo Acevedo; Sonsire Fernández; Caridad Zayas; Armando Acosta; Maria Elena Sarmiento; Valerie A Ferro; Einar Rosenqvist; Concepcion Campa; Daniel Cardoso; Luis Garcia; Jose Luis Perez
Journal:  Front Immunol       Date:  2014-03-24       Impact factor: 7.561

2.  Bioengineered polyester beads co-displaying protein and carbohydrate-based antigens induce protective immunity against bacterial infection.

Authors:  Majela González-Miró; Laura M Rodríguez-Noda; Mildrey Fariñas-Medina; Barbara Cedré-Marrero; Sandra Madariaga-Zarza; Caridad Zayas-Vignier; Mabel Hernández-Cedeño; Torsten Kleffmann; Dagmar García-Rivera; Vicente Vérez-Bencomo; Bernd H A Rehm
Journal:  Sci Rep       Date:  2018-01-30       Impact factor: 4.379

3.  Using vaccine Immunostimulation/Immunodynamic modelling methods to inform vaccine dose decision-making.

Authors:  Sophie J Rhodes; Jeremie Guedj; Helen A Fletcher; Thomas Lindenstrøm; Thomas J Scriba; Thomas G Evans; Gwenan M Knight; Richard G White
Journal:  NPJ Vaccines       Date:  2018-09-17       Impact factor: 7.344

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.